Ipilimumab in the Adjuvant Setting for MelanomaByVernon K. Sondak, MDOctober 18th 2013Vernon K. Sondak, MD, chair of the Department of Cutaneous Oncology at Moffitt Cancer Center, discusses the use of ipilimumab in the adjuvant setting for patients with melanoma.
Personalized Medicine in MelanomaByVernon K. Sondak, MDOctober 9th 2013Vernon K. Sondak, MD, talks about personalized medicine when treating patients with melanoma.